R. Ishisaka et al., A part of the transmembrane domain of pro-TNF can function as a cleavable signal sequence that generates a biologically active secretory form of TNF, J BIOCHEM, 126(2), 1999, pp. 413-420
To determine the minimum requirement in the 76-residue leader sequence of p
ro-tumor necrosis factor (TNF) for membrane translocation across the endopl
asmic reticulum (ER) and for the maturation of pro-TNF, we constructed pro-
TNF mutants in which a part of the transmembrane domain of pro-TNF was dire
ctly linked to the N-terminus of the mature domain, and evaluated their tra
nslocational behavior across the ER-membrane and their secretion from the t
ransfected cells, The in vitro translation/translocation assay involving a
canine pancreatic microsomal membrane system including a mutant, Delta-75-4
7 7, -32-1, revealed that the N-terminal half of the transmembrane domain o
f pro-TNF consisting of 14 residues functioned as a cleavable signal sequen
ce; it generated a cleaved form of TNF having a molecular mass similar to t
hat of mature TNF, Analysis of the cleavage site by site-directed mutagenes
is indicated that the site was inside the leader sequence of this mutant. W
hen the mutant, Delta-75-47, -32-1, was expressed in COS-1 cells, efficient
secretion of a biologically active soluble TNF was observed. Further delet
ion of the hydrophobic domain from this mutant inhibited the translocation,
indicating that some extent of hydrophobicity is indispensable for the mem
brane translocation of the mature domain of TNF, Thus, the N-terminal half
of the transmembrane domain of pro-TNF could function as a cleavable signal
sequence when linked to the mature domain of TNF, and secretion of a biolo
gically active secretory form of TNF could be achieved with this 14-residue
hydrophobic segment. In intact pro-TNF, however, this 14-residue sequence
could not function as a cleavable signal sequence during intracellular proc
essing, indicating that the remainder of the 76-residue leader sequence of
pro-TNF inhibits the signal peptide cleavage and thus enables the leader se
quence to function as a type II signal-anchor sequence that generates a tra
nsmembrane form of TNF.